Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits

Glaucoma is the second cause of blindness worldwide. Frequent administration of traditional topical dosage forms may lead to patient incompliance and failure of treatment. Our study aims to formulate proniosomal gel formulations that sustain the release of the water-soluble anti-glaucoma drug Dorzol...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouda, Nagwa Hussein, Abdelrehim, Randa Tag, Hegazy, Doaa Abdelmagid, Habib, Basant Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058483/
https://www.ncbi.nlm.nih.gov/pubmed/29869516
http://dx.doi.org/10.1080/10717544.2018.1477861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058483/
https://www.ncbi.nlm.nih.gov/pubmed/29869516
http://dx.doi.org/10.1080/10717544.2018.1477861

Ejemplares similares